Form 8-K - Current report:
SEC Accession No. 0001104659-23-030852
Filing Date
2023-03-10
Accepted
2023-03-10 07:51:43
Documents
16
Period of Report
2023-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239035d1_8k.htm   iXBRL 8-K 48379
2 EXHIBIT 5.1 tm239035d1_ex5-1.htm EX-5.1 8842
3 EXHIBIT 10.1 tm239035d1_ex10-1.htm EX-10.1 273201
4 EXHIBIT 10.2 tm239035d1_ex10-2.htm EX-10.2 103005
8 GRAPHIC tm239035d1_ex5-1img01.jpg GRAPHIC 3363
  Complete submission text file 0001104659-23-030852.txt   704303

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20230310.xsd EX-101.SCH 3024
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20230310_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20230310_pre.xml EX-101.PRE 22589
10 EXTRACTED XBRL INSTANCE DOCUMENT tm239035d1_8k_htm.xml XML 3613
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 23721624
SIC: 2836 Biological Products, (No Diagnostic Substances)